Neptune Wellness Solutions Inc.
DelistedCIK 1401395fmd_0Q93K3CW3APFS51JJCRHS11XA0Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Apr 01, 2017 to Dec 31, 2023, 15 periods
| Line item | FY2021 | FY2022 | FY2023 |
|---|---|---|---|
| Total revenues | 35 | 49 | 53 |
| Cost of revenue | 63 | 56 | 55 |
| Net interest income | 0 | 0 | 0 |
| Gross profit | (27) | (8) | (2) |
| Research and development | 2 | 1 | 0 |
| Selling, general and administrative | 64 | 61 | 46 |
| Operating income | (131) | (89) | (103) |
| Interest expense | 0 | 1 | 2 |
| Other non-operating income (expense) | 3 | 4 | 14 |
| Income before taxes | (128) | (84) | (89) |
| Income tax expense | (3) | – | – |
| Net income from continuing operations | (124) | – | – |
| Net income | (123) | (75) | (60) |
| Net income to common shareholders | – | (75) | (60) |